Clinical Trial Update: Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating irinotecan-eluting beads with gemcitabine and cisplatin or carboplatin for unresectable intrahepatic cholangiocarcinoma has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)
• Irinotecan (Camptosar) (Irinotecan)
• Platinol (cisplatin)

Snippet

Sponsor: Robert C. Martin | Conditions: Unresectable Intrahepatic Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-01-13